Chief Executive Flemming Ornskov says Dublin-based drugs company was pursuing a number of large M&A deals when US rival made its offer.
from WSJ.com: US Business http://ift.tt/1yUvmth
via IFTTT
from WSJ.com: US Business http://ift.tt/1yUvmth
via IFTTT
No comments:
Post a Comment